FDA NDA · NDA213702
ZEPZELCA
Sponsor: JAZZ
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
NDA213702
TYPE
NDA
ORIGINAL APPROVAL
2020-06-15
LATEST ACTION
2026-09-30
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
ZEPZELCA · ReferencePrescription
LURBINECTEDIN 4MG/VIAL · POWDER · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →